Teladoc Health Inc vs TotalEnergies SE — how do they compare? Teladoc Health Inc trades at $5.77 (market cap $1.01B), while TotalEnergies SE trades at $86.11 (market cap $191.82B). The key difference: TotalEnergies SE is far larger — about 189.9× Teladoc Health Inc's market cap, and TotalEnergies SE pays a 4.93% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Teladoc Health Inc for 39 Days and TotalEnergies SE for 90 Days on average.
| TDOC | TTE | |
|---|---|---|
Market Cap | $1.01B | $191.82B |
Volume | 4,668,477 | 3,311,339 |
Sector | Health | Energy |
52-Week High | $9.72 | $93.60 |
52-Week Low | $4.47 | $57.39 |
Typical Hold Time | 39 Days | 90 Days |
Enterprise Value | $1.27B | $222.81B |
Dividend Yield | — | 4.93% |
Signals from Pluang's Aura AI — not financial advice
TDOC trades at $5.54, down 0.36% on the day, with a bearish technical signal and mixed earnings history. The company reported revenue of $2.53B in 2025 but a net loss of $200.32M, reflecting ongoing profitability challenges. Analyst consensus is a 'Hold' with a $8.83 price target, indicating potential upside. Recent news includes a CFO transition and legal investigations, adding to investor uncertainty.
The outlook remains cautious due to persistent losses and competitive pressures, though valuation metrics like P/S of 0.4 and EV/EBITDA of 5.89 suggest the stock is undervalued. Key risks include weak cash flow trends and BetterHelp segment volatility. Upside depends on execution in integrated care and cost management.
TotalEnergies (TTE) trades at $86.02, up 2.13% for the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported mixed quarterly earnings, with Q1 and Q2 2026 beats but a Q4 2025 miss. Revenue declined to $182.34B in 2025, though net income margin held at 9.08%. Recent news highlights a $10B investment in Argentina and a strategic focus on boosting cash flow and dividends through 2030.
TTE offers value with a P/E of 10.77 and strong cash generation, supported by a 55.88% analyst buy rating and a $95.33 consensus price target. Risks include declining revenue trends, geopolitical exposure, and energy price volatility. The stock presents a balanced opportunity for income and growth investors, with upside potential if execution on expansion plans materializes.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.5 million barrels of liquids and 7.2 billion cubic feet of natural gas per day. At year-end 2020, reserves stood at 12.1 billion barrels of oil equivalent, 45% of which are liquids. During 2021, it had LNG sales of 42 Mt. The company owns interests in refineries with capacity of nearly 1.8 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. It also holds a 19% interest in Russian oil company Novatek. At year-end, its gross installed renewable power generation capacity was 10.3 GW.
Read more on TTE →